CP-870,893
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CP-870,893, covering 2012-10-31 to 2012-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Dose Finding Study Of CP-870,893, An Immune System Stimulating Antibody, In Combination With Paclitaxel And Carboplatin For Patients With Metastatic Solid Tumors [Phase 1]